美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Iambic Therapeutics

14.67

-1.1300-7.15%

盤後：14.670.00000.00%16:14 EDT

成交量：49.36萬

成交額：736.24萬

市值：6.95億

市盈率：-7.38

高：15.47

開：15.40

低：14.50

收：15.80

52周最高：25.00

52周最低：14.10

股本：4,740.08萬

流通股本：937.50萬

量比：0.28

換手率：5.27%

股息：- -

股息率：- -

每股收益(TTM):-1.9880

每股收益(LYR):-3.5749

淨資產收益率：-54.21%

總資產收益率：-29.35%

市淨率：-2.99

市盈率(LYR):-4.10

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Iambic Therapeutics

交易所：

NASDAQ

成立時間：

2019

員工人數：

171

公司地址：

5627 Oberlin Drive,Suite 120,San Diego,California,United States

官網：

http://www.iambic.ai

郵編：

92121

電話：

傳真：

- -

簡介：

Iambic Therapeutics, Inc.於2019年10月在特拉華州註冊成立，是一家技術和臨床階段生命科學公司，利用分子超級智能平台推動生物製藥研發轉型。該平台將大規模人工智能與自動化、可擴展的化學和生物學實驗相結合，以發現和開發新型藥物。

董事

名稱

職位

Thomas Miller

Chief Executive Officer and Director

Frederick Manby

Chief Technology Officer and Director

Evan Rachlin

Director

Kurt von Emster

Director

Mary Tagliaferri

Director

R. Jacob Vogelstein

Director

Samit Hirawat

Director

Shalini Sharp

Director

William Rastetter

Director

股東

名稱

職位

Thomas Miller

Chief Executive Officer and Director

Michael Secora

Chief Corporate Development Officer and Chief Financial Officer

Frederick Manby

Chief Technology Officer and Director

Neil Josephson

Chief Medical Officer

Peter Olson

Chief Scientific Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/IAM/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IAM\",,,,,undefined,":{"symbol":"IAM","market":"US","secType":"STK","nameCN":"Iambic Therapeutics","latestPrice":14.67,"timestamp":1792699200000,"preClose":15.8,"halted":0,"volume":493626,"hourTrading":{"tag":"盘后","latestPrice":14.67,"preClose":14.67,"latestTime":"16:14 EDT","volume":763,"amount":11178.609994999999,"timestamp":1792700047266,"change":0,"changeRate":0,"amplitude":0.010907},"delay":0,"changeRate":-0.0715189873417722,"floatShares":9375000,"shares":47400796,"eps":-1.988,"marketStatus":"盤後交易","change":-1.13,"latestTime":"10-22 16:16:50 EDT","open":15.4,"high":15.47,"low":14.5,"amount":7362438,"amplitude":0.061392,"askPrice":15.19,"askSize":500,"bidPrice":14.5,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.988,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1792713600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1792036800000,"exchange":"NASDAQ","adjPreClose":15.8,"preHourTrading":{"tag":"盘前","latestPrice":15.37,"preClose":15.8,"latestTime":"09:19 EDT","volume":751,"amount":11513.217515999999,"timestamp":1792675146362,"change":-0.43,"changeRate":-0.027215,"amplitude":0.020253},"postHourTrading":{"tag":"盘后","latestPrice":14.67,"preClose":14.67,"latestTime":"16:14 EDT","volume":763,"amount":11178.609994999999,"timestamp":1792700047266,"change":0,"changeRate":0,"amplitude":0.010907},"volumeRatio":0.279551},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IAM\",,,,,undefined,":{"symbol":"IAM","floatShares":9375000,"roa":"-29.35%","roe":"-54.21%","lyrEps":-3.57489,"volumeRatio":0.279551,"shares":47400796,"dividePrice":0,"high":15.47,"amplitude":0.061392,"preClose":15.8,"low":14.5,"week52Low":14.1,"pbRate":"-2.99","psRate":"38.10","week52High":25,"institutionHeld":0,"latestPrice":14.67,"committee":-0.960784,"eps":-1.988,"divideRate":0,"volume":493626,"delay":0,"ttmEps":-1.988,"open":15.4,"prevYearClose":16,"prevWeekClose":23.81,"prevMonthClose":16,"prevQuarterClose":16,"fiveDayClose":18.91,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IAM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IAM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IAM","date":"2026-10-14","current":-7.379276,"percent":1,"low":-8.047161,"twenty":-8.047161,"median":-8.047161,"eighty":-8.047161,"high":-8.047161,"avg":-8.047161,"sd":0,"marketCap":758412736},"quantilePoints":[{"date":"2026-10-14","current":-8.047161,"twenty":-8.047161,"median":-8.047161,"eighty":-8.047161,"marketCap":758412736}],"updateTime":1792700210713},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":697621497,"yearFounded":2019,"employeeNum":171,"address":"5627 Oberlin Drive,Suite 120,San Diego,California,United States","zipCode":"92121","officePhone":"(619) 330-5499","fiscalYearEnd":"12-30"},"stockCompanyDetail":{"websiteUrl":"http://www.iambic.ai","stockEarnings":[{"period":"1week","weight":-0.0125},{"period":"ytd","weight":-0.0125}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Iambic Therapeutics, Inc.於2019年10月在特拉華州註冊成立，是一家技術和臨床階段生命科學公司，利用分子超級智能平台推動生物製藥研發轉型。該平台將大規模人工智能與自動化、可擴展的化學和生物學實驗相結合，以發現和開發新型藥物。","exchange":"NASDAQ","name":"Iambic Therapeutics","nameEN":"Iambic Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IAM\",market:\"US\",,,undefined,":{"directors":[{"name":"Thomas Miller","position":"Chief Executive Officer and Director"},{"name":"Frederick Manby","position":"Chief Technology Officer and Director"},{"name":"Evan Rachlin","position":"Director"},{"name":"Kurt von Emster","position":"Director"},{"name":"Mary Tagliaferri","position":"Director"},{"name":"R. Jacob Vogelstein","position":"Director"},{"name":"Samit Hirawat","position":"Director"},{"name":"Shalini Sharp","position":"Director"},{"name":"William Rastetter","position":"Director"}],"executives":[{"name":"Thomas Miller","position":"Chief Executive Officer and Director"},{"name":"Michael Secora","position":"Chief Corporate Development Officer and Chief Financial Officer"},{"name":"Frederick Manby","position":"Chief Technology Officer and Director"},{"name":"Neil Josephson","position":"Chief Medical Officer"},{"name":"Peter Olson","position":"Chief Scientific Officer"}]}}}